Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2020-04-23 Major Shareholding Noti…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Change in substantial holding 6 pages 340.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of Change of Interests of Substantial Holder filed under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder (The Bank of New York Mellon Corporation and its group entities) in Genetic Technologies Limited. The form includes specifics about shareholdings, changes in relevant interests, and associations, which are typical for notifications of substantial shareholding changes. There is no financial performance data, earnings information, or management discussion. The document is regulatory in nature, reporting a change in major shareholding levels as required by law. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length (8450 characters) supports it being a full notice rather than a brief announcement or certification.
2020-04-23 English
Change in substantial holding 6 pages 353.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of Change of Interests of Substantial Holder filed under the Corporations Act 2001. It details changes in voting power and relevant interests of The Bank of New York Mellon Corporation and its group entities in Genetic Technologies Limited. The form includes dates of changes, previous and present voting power, and annexures listing associated entities and detailed interests. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding changes.
2020-04-22 English
Closing of US$1.44 Million Registered Direct Offering 2 pages 180.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement titled 'Genetic Technologies Announces Closing of US$1.44 Million Registered Direct Offering.' It details the closing of a registered direct offering of American Depositary Shares, the use of proceeds, and references to the SEC registration statement and prospectus. There are no financial statements or detailed financial performance data included. The content focuses on fundraising and capital raising activities. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 5523 characters, which is sufficient for a detailed announcement but does not contain a full financial report. Hence, the classification is CAP with high confidence.
2020-04-22 English
Section 708A Notice 1 page 138.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX Market Announcement regarding a Section 708A(5)(e) Notification under the Corporations Act 2001. It informs about the issue of ordinary shares and the related exemption from disclosure requirements. The document is short (1531 characters) and serves as a formal notification rather than a detailed financial report or analysis. It does not contain financial statements, management discussion, or audit information. It is an announcement related to capital issuance and compliance with regulatory disclosure exemptions. Therefore, it fits best under Capital/Financing Update (CAP).
2020-04-22 English
Ceasing to be a substantial holder 2 pages 162.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests of a substantial shareholder in Genetic Technologies Limited, including dates and shareholdings. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is regulatory in nature and specifically reports on shareholding changes, not financial results or management changes.
2020-04-22 English
Appendix 3G 13 pages 247.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3G form submitted to the ASX (Australian Securities Exchange) regarding the notification of issue, conversion, or payment up of equity securities. It details the issuance of new warrants as part consideration for placement agent services, including specifics such as security description, number of securities, and ranking. The document is a regulatory announcement about a capital/financing activity, specifically the issuance of new securities. It is not a full financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive details about the securities issued. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-04-22 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.